IntraOp Medical has received $2.4 million of new equity from new and existing investors.
Under the terms of the financing, IntraOp may raise an additional $600,000 in equity by Feb 13.
“This financing is part of our continuing strategy to ensure that IntraOp has the resources to address the large market for intraoperative electron beam radiation delivered by the Mobetron, especially in the areas of breast and skin cancer,” said Oliver Janssen, chairman of the board of IntraOp.
John Powers, CEO of IntraOp, added, “This capital allows us to support and accelerate the penetration of our existing markets in North America, Europe and Japan and emerging markets in China, Korea and India.”
IntraOp has delivered 24 systems worldwide, with 10 systems in North America, 10 systems in Europe and four in Japan and China, the company said.